J M Schildkraut

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi request reprint Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk
    Joellen M Schildkraut
    Department of Community and Family Medicine, Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, NC 27710, USA
    J Natl Cancer Inst 94:32-8. 2002
  2. ncbi request reprint Analgesic drug use and risk of ovarian cancer
    Joellen M Schildkraut
    Duke Comprehensive Cancer Center, Cancer Prevention, Detection and Control Research Program, Duke University Medical Center, Durham, North Carolina 27710, USA
    Epidemiology 17:104-7. 2006
  3. pmc Primary peritoneal and ovarian cancers: an epidemiological comparative analysis
    Delores J Grant
    Department of Biology, North Carolina Central University, JLC Biomedical Biotechnology Research Institute, Durham, NC, USA
    Cancer Causes Control 21:991-8. 2010
  4. pmc Folic acid supplementation before and during pregnancy in the Newborn Epigenetics STudy (NEST)
    Cathrine Hoyo
    Department of Community and Family Medicine and Program of Cancer Detection, Prevention and Control, Duke University, PO Box 104006, Durham, NC 27710, USA
    BMC Public Health 11:46. 2011
  5. pmc Activating mutation in MET oncogene in familial colorectal cancer
    Deborah W Neklason
    Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA
    BMC Cancer 11:424. 2011
  6. pmc Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer
    Kristin L White
    Mayo Clinic College of Medicine, Rochester, MN, USA
    BMC Cancer 9:170. 2009
  7. pmc Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer
    Joellen M Schildkraut
    Comprehensive Cancer Center, Department of Community and Family Medicine, Duke University Medical Center, and Department of Statistical Science, Duke University, Durham, North Carolina, USA
    Cancer Res 69:2349-57. 2009
  8. ncbi request reprint Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer
    Joellen M Schildkraut
    Department of Community and Family Medicine, Duke University Medical Center, Box 2949, Durham, NC 27710, USA
    Cancer Epidemiol Biomarkers Prev 16:473-80. 2007
  9. doi request reprint Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup
    Joellen M Schildkraut
    Department of Community and Family Medicine, Duke University Medical Center, Box 2949, Durham, NC 27710, USA
    Cancer Epidemiol Biomarkers Prev 17:585-93. 2008
  10. ncbi request reprint IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men
    Joellen M Schildkraut
    Program of Cancer Prevention, Detection and Control Research, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA
    Cancer Epidemiol Biomarkers Prev 14:403-8. 2005

Research Grants

  1. MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER
    Joellen Schildkraut; Fiscal Year: 2007
  2. The Molecular Epidemiology Of Ovarian Cancer
    Joellen M Schildkraut; Fiscal Year: 2010
  3. Meningioma: Risk Factors and Quality of Life
    Joellen Schildkraut; Fiscal Year: 2007
  4. The Molecular Epidemiology Of Ovarian Cancer
    Joellen Schildkraut; Fiscal Year: 2006
  5. MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER
    Joellen Schildkraut; Fiscal Year: 2001
  6. MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER
    Joellen Schildkraut; Fiscal Year: 2001
  7. MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER
    Joellen Schildkraut; Fiscal Year: 2002
  8. Meningioma: Risk Factors and Quality of Life
    Joellen Schildkraut; Fiscal Year: 2009
  9. CAROLINA AND GEORGIA GENETICS NETWORK CENTER
    Joellen Schildkraut; Fiscal Year: 2004
  10. The Molecular Epidemiology Of Ovarian Cancer
    Joellen Schildkraut; Fiscal Year: 2004

Detail Information

Publications50

  1. ncbi request reprint Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk
    Joellen M Schildkraut
    Department of Community and Family Medicine, Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, NC 27710, USA
    J Natl Cancer Inst 94:32-8. 2002
    ..In this study, we investigate the relationship between the progestin and estrogen potency in combination OCs and the risk of developing ovarian cancer...
  2. ncbi request reprint Analgesic drug use and risk of ovarian cancer
    Joellen M Schildkraut
    Duke Comprehensive Cancer Center, Cancer Prevention, Detection and Control Research Program, Duke University Medical Center, Durham, North Carolina 27710, USA
    Epidemiology 17:104-7. 2006
    ..Previous epidemiologic research suggests that analgesic use may reduce the risk of ovarian cancer, although results are not consistent...
  3. pmc Primary peritoneal and ovarian cancers: an epidemiological comparative analysis
    Delores J Grant
    Department of Biology, North Carolina Central University, JLC Biomedical Biotechnology Research Institute, Durham, NC, USA
    Cancer Causes Control 21:991-8. 2010
    ..A larger study to determine risk factors for invasive serous PPC is warranted...
  4. pmc Folic acid supplementation before and during pregnancy in the Newborn Epigenetics STudy (NEST)
    Cathrine Hoyo
    Department of Community and Family Medicine and Program of Cancer Detection, Prevention and Control, Duke University, PO Box 104006, Durham, NC 27710, USA
    BMC Public Health 11:46. 2011
    ..The primary objective is to estimate the proportion of women taking folic acid (FA) doses exceeding the TUL before and during pregnancy, and to identify correlates of high FA use...
  5. pmc Activating mutation in MET oncogene in familial colorectal cancer
    Deborah W Neklason
    Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA
    BMC Cancer 11:424. 2011
    ..Familial colorectal cancer has been linked to chromosome 7q31 by multiple affected relative pair studies. The MET proto-oncogene which resides in this chromosomal region is considered a candidate for genetic susceptibility...
  6. pmc Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer
    Kristin L White
    Mayo Clinic College of Medicine, Rochester, MN, USA
    BMC Cancer 9:170. 2009
    ..Inhibitors of kappaB (IkappaB) prevent NF-kappaB activation by sequestering NF-kappaB proteins in the cytoplasm until IkappaB proteins are phosphorylated and degraded...
  7. pmc Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer
    Joellen M Schildkraut
    Comprehensive Cancer Center, Department of Community and Family Medicine, Duke University Medical Center, and Department of Statistical Science, Duke University, Durham, North Carolina, USA
    Cancer Res 69:2349-57. 2009
    ..This large study provides statistical evidence for a small increase in risk of ovarian cancer associated with common variants in the TP53 region...
  8. ncbi request reprint Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer
    Joellen M Schildkraut
    Department of Community and Family Medicine, Duke University Medical Center, Box 2949, Durham, NC 27710, USA
    Cancer Epidemiol Biomarkers Prev 16:473-80. 2007
    ..Two trinucleotide repeat polymorphisms have been described in exon 1 of the androgen receptor (AR) gene that may affect its function. Previous studies of ovarian cancer and AR repeat polymorphisms have been inconsistent...
  9. doi request reprint Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup
    Joellen M Schildkraut
    Department of Community and Family Medicine, Duke University Medical Center, Box 2949, Durham, NC 27710, USA
    Cancer Epidemiol Biomarkers Prev 17:585-93. 2008
    ..The objective of this study was to determine whether cyclin E overexpression defines an etiologically distinct subgroup of ovarian cancer...
  10. ncbi request reprint IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men
    Joellen M Schildkraut
    Program of Cancer Prevention, Detection and Control Research, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA
    Cancer Epidemiol Biomarkers Prev 14:403-8. 2005
    ..Further research is needed to confirm these findings...
  11. ncbi request reprint Environmental contaminants and body fat distribution
    J M Schildkraut
    Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Cancer Epidemiol Biomarkers Prev 8:179-83. 1999
    ..In addition, BMI may affect circulating levels of contaminants and should also be considered a potentially important modifying factor for exposure to lipophilic substances...
  12. pmc Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer
    Joellen M Schildkraut
    Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, United States of America
    PLoS ONE 5:e10061. 2010
    ....
  13. ncbi request reprint Prognostic factors in early-onset epithelial ovarian cancer: a population-based study
    J M Schildkraut
    Department of Cancer Prevention, Detection, and Control Research Program, Duke University Medical Center, Durham, North Carolina 27710, USA
    Obstet Gynecol 95:119-27. 2000
    ..To investigate the clinical prognostic factors that influence ovarian cancer survival in women with early-onset epithelial ovarian cancer using population-based data...
  14. ncbi request reprint Age at natural menopause and the risk of epithelial ovarian cancer
    J M Schildkraut
    Program for Prevention, Detection, and Control Research, Duke Comprehensive Cancer Center, Durham, North Carolina 27710, USA
    Obstet Gynecol 98:85-90. 2001
    ..To investigate the relationship between age at natural menopause and risk of developing epithelial ovarian cancer...
  15. ncbi request reprint Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer
    Robert M Wenham
    Department of Obstetrics and Gynecology Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Clin Cancer Res 9:4396-403. 2003
    ..We have examined whether BRCA2 N372H or common amino acid-changing polymorphisms in BRCA1 predispose to ovarian cancer...
  16. pmc Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women
    Rachel T Palmieri
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Cancer Epidemiol Biomarkers Prev 17:3567-72. 2008
    ..This analysis shows the importance of consortia, like the OCAC, in either confirming or refuting the validity of putative findings in studies with smaller sample sizes. (Cancer Epidemiol Biomarkers Prev 2008;17(12):3567-72)...
  17. ncbi request reprint No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina
    Johnathan M Lancaster
    Department of Obstetrics and Gynecology Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Cancer Epidemiol Biomarkers Prev 12:226-7. 2003
  18. ncbi request reprint Anthropometric measurements and epithelial ovarian cancer risk in African-American and White women
    Cathrine Hoyo
    Department of Community and Family Medicine, Duke University Medical Center, 2424 Erwin Rd, Hock Plaza, Ste 602, Durham, NC 27710, USA
    Cancer Causes Control 16:955-63. 2005
    ..0; 95% CI = 0.7-1.4). These findings support the hypothesis that obesity is an important risk factor of ovarian cancer among African-Americans and Whites and also suggest that height may be a risk factor specific to African-Americans...
  19. ncbi request reprint Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor
    M F Vine
    Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Gynecol Oncol 83:466-71. 2001
    ..The objective was to describe and compare types and duration of symptoms among women with invasive versus borderline ovarian tumors...
  20. ncbi request reprint Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk
    Monique A Spillman
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University, DUMC Box 3079, Durham, NC 27710, USA
    Gynecol Oncol 97:543-9. 2005
    ..It has been suggested that the 6A allele of the type I TGFbeta receptor (TGFbetaR1) polyalanine repeat tract polymorphism may increase susceptibility to various types of cancer including ovarian cancer...
  21. ncbi request reprint Early onset baldness and prostate cancer risk
    W Denmark-Wahnefried
    Division of Urology Duke University Medical Center, Durham, North Carolina 27710, USA
    Cancer Epidemiol Biomarkers Prev 9:325-8. 2000
    ....
  22. pmc A prospective study of weight gain after premenopausal hysterectomy
    Patricia G Moorman
    Department of Community and Family Medicine, Box 2949, Duke University Medical Center, 2424 Ervin Road, Suite 602, Durham, NC 27705, USA
    J Womens Health (Larchmt) 18:699-708. 2009
    ..The purpose of this analysis was to assess weight gain in premenopausal women in the first year after hysterectomy compared with a control group of women with intact uteri and ovaries...
  23. pmc Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men
    Cathrine Hoyo
    Department of Community and Family Medicine, Duke University Medical Center, Box 2914, Durham, NC 27710, USA
    J Natl Med Assoc 101:711-6. 2009
    ..Factors associated with variation in circulating levels of these peptide hormones remain unclear...
  24. doi request reprint Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium
    Andrew Berchuck
    Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC 27710, USA
    Adv Exp Med Biol 622:53-67. 2008
  25. pmc IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas
    Cathrine Hoyo
    Department of Community and Family Medicine, Duke University, Durham, NC 27710, USA
    Int J Cancer 125:2673-8. 2009
    ..5002G > A genotype and EGA was not evident. These findings suggest that nonsynonymous polymorphisms in M6P/IGF2R may contribute to the risks of EGA and noncardia adenocarcinomas. Larger studies are required to confirm these findings...
  26. pmc Ovarian cancer risk factors in African-American and white women
    Patricia G Moorman
    Duke University Medical Center, 2424 Erwin Road, Suite 602, Durham, NC 27705, USA
    Am J Epidemiol 170:598-606. 2009
    ..There is a clear need for further research on etiologic factors for ovarian cancer in African-American women...
  27. pmc Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls
    Dora Il'yasova
    Department of Community and Family Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Cancer Epidemiol Biomarkers Prev 18:1232-8. 2009
    ..These controls seem to present a reasonable choice for clinic-centered case-control studies...
  28. pmc Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women
    Patricia G Moorman
    Department of Community and Family Medicine, Cancer Prevention, Detection and Control Research Program, Duke University Medical Center, Durham, NC 27705, USA
    Am J Epidemiol 167:1059-69. 2008
    ..Findings suggest that associations between ovarian cancer and reproductive characteristics vary by menopausal status. Additional research is needed to further elucidate risk factors for postmenopausal disease...
  29. pmc Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy
    Celette Sugg Skinner
    Duke University Medical Center, Durham, NC 27710, USA
    J Gen Intern Med 20:360-5. 2005
    ..Most (79%) reported CRIS had "caused" their discussion. CRIS is an easily used, disseminable program that showed promising results in primary care settings...
  30. ncbi request reprint Menopausal hormones and risk of ovarian cancer
    Patricia G Moorman
    Department of Community and Family Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Am J Obstet Gynecol 193:76-82. 2005
    ..The objective of this study was to determine if use of menopausal hormones was associated with ovarian cancer and if risk varied by type of hormone used...
  31. ncbi request reprint Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers
    Andrew Berchuck
    Division of Gynecologic Oncology, Duke University Medical Center, Box 3079, Durham, NC 27710, USA
    Cancer Epidemiol Biomarkers Prev 13:2141-7. 2004
    ..In this study, we sought to determine whether this polymorphism affects ovarian cancer risk...
  32. ncbi request reprint Racial differences in enrolment in a cancer genetics registry
    Patricia G Moorman
    Cancer Prevention Detection and Control Research Program, Duke University Medical Center, 239 Hanes House, Trent Drive, Box 2949, Durham, NC 27710, USA
    Cancer Epidemiol Biomarkers Prev 13:1349-54. 2004
    ..Most studies have little information about nonparticipants, making it difficult to identify characteristics associated with enrolment and how they might vary by race...
  33. pmc Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis
    Patricia G Moorman
    Cancer Prevention Detection and Control Research Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC 27705, USA
    Breast Cancer Res Treat 124:441-51. 2010
    ..However, our results should be interpreted cautiously given the overall inconsistency in the epidemiologic literature on modifiers of BRCA1 and BRCA2...
  34. ncbi request reprint Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States)
    Patricia G Moorman
    Cancer Prevention, Detection, and Control Research Program, Department of Community and Family Medicine, Duike Universiti Medical Center, Durham, NC 27710, USA
    Cancer Causes Control 13:807-11. 2002
    ..To compare two methods for calculating lifetime ovulatory cycles (LOC) to determine if more detailed menstrual cycle information results in stronger associations with ovarian cancer...
  35. pmc Grade-specific prostate cancer associations of IGF1 (CA)19 repeats and IGFBP3-202A/C in blacks and whites
    Cathrine Hoyo
    Department of Community and Family Medicine, Hanes House Room 347, Trent Drive, Box 2914, Medical Center, Duke University Medical Center, Durham, NC 27710, USA
    J Natl Med Assoc 99:718-22. 2007
    ..If confirmed in larger studies, these findings support the hypothesis that the association between IGFBP3 C allele and prostate cancer is grade specific in both ethnic groups...
  36. ncbi request reprint Pre-counseling education materials for BRCA testing: does tailoring make a difference?
    Celette Sugg Skinner
    Duke University Medical Center, Department of Community and Family Medicine and the Duke Comprehensive Cancer Center, Durham, NC 27710, USA
    Genet Test 6:93-105. 2002
    ..91% NPM; p < 0.05). TPMs showed an advantage in increasing knowledge and enhancing accuracy of perceived risk. Both are critical components of informed decision making...
  37. ncbi request reprint Antidepressant medication use [corrected] and risk of ovarian cancer
    Patricia G Moorman
    Cancer Prevention, Detection, and Control Research Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Obstet Gynecol 105:725-30. 2005
    ..The objective of this paper was to evaluate whether women with ovarian cancer were more likely to report past use of antidepressants than control women...
  38. pmc Recreational physical activity and ovarian cancer risk and survival
    Patricia G Moorman
    Cancer Prevention, Detection and Control Research Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC 27705, USA
    Ann Epidemiol 21:178-87. 2011
    ..We examined associations between self-reported physical activity and ovarian cancer risk and survival in a population-based, case-control study in North Carolina...
  39. doi request reprint Factors associated with African Americans' enrollment in a national cancer genetics registry
    C S Skinner
    Duke Comprehensive Cancer Center, Durham, NC, USA
    Community Genet 11:224-33. 2008
    ..Education was also bivariately associated with enrollment, but mediation analysis indicated that the operational mechanism of education's influence on enrollment was through trust...
  40. ncbi request reprint Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls
    Marilyn F Vine
    Cancer Prevention, Detection and Control Research Program, Box 2949, Duke University Medical Center, Durham, NC 27710, USA
    Gynecol Oncol 90:75-82. 2003
    ..The goal of this study was to characterize types, frequency, combinations, and relative onset of symptoms among ovarian cancer cases and controls...
  41. pmc Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring
    A C Vidal
    Division of Epidemiology, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC 27710, USA
    Int J Obes (Lond) 37:907-13. 2013
    ..In this study, we evaluated the association between maternal antibiotic use and LBW and examined the potential role of altered DNA methylation that controls growth regulatory imprinted genes in these associations...
  42. pmc Validity of models for predicting BRCA1 and BRCA2 mutations
    Giovanni Parmigiani
    The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland 21205 2011, USA
    Ann Intern Med 147:441-50. 2007
    ..At least 7 models for estimating the probabilities of having a mutation are used widely in clinical and scientific activities; however, the merits and limitations of these models are not fully understood...
  43. pmc Consortium analysis of 7 candidate SNPs for ovarian cancer
    Susan J Ramus
    Translational Research Laboratory, University College London EGA Institute for Women s Health, London, United Kingdom
    Int J Cancer 123:380-8. 2008
    ..These null results for SNPs identified from relatively large initial studies shows the importance of replicating associations by a consortium approach...
  44. pmc Characterization of BRCA1 and BRCA2 mutations in a large United States sample
    Sining Chen
    Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    J Clin Oncol 24:863-71. 2006
    ..Existing studies have focused on Ashkenazi Jews (AJ) or on families from outside the United States. In this article, we consider the US population using the largest US-based cohort to date of both AJ and non-AJ families...
  45. pmc Genetic variation in the one-carbon transfer pathway and ovarian cancer risk
    Linda E Kelemen
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer Res 68:2498-506. 2008
    ..Interventions with modifiable factors such as multivitamin intake may reduce risk...
  46. ncbi request reprint Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15261, USA
    Am J Obstet Gynecol 191:733-40. 2004
    ..We investigated whether the odds ratios for ovarian cancer that were associated with oral contraceptive use, childbearing, hysterectomy, and tubal ligation differ among women with and without endometriosis...
  47. ncbi request reprint Estrogen bioactivation, genetic polymorphisms, and ovarian cancer
    Thomas A Sellers
    Division of Cancer Prevention and Control, H Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33602, USA
    Cancer Epidemiol Biomarkers Prev 14:2536-43. 2005
    ..015). Although preliminary, this study provides some support for the hypothesis that low-penetrance susceptibility alleles may influence risk of epithelial ovarian cancer...
  48. pmc Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer
    Thomas A Sellers
    Division of Cancer Prevention and Control, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
    Cancer Epidemiol Biomarkers Prev 17:397-404. 2008
    ..10 frequency; odds ratio, 0.07; P = 0.01) compared with the most common haplotype (0.39 frequency). These results suggest that genetic polymorphisms in the glycoslyation process may be novel risk factors for ovarian cancer...
  49. ncbi request reprint Epidemiology of intracranial meningioma
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06520 8034, USA
    Neurosurgery 57:1088-95; discussion 1088-95. 2005
    ..This review highlights current knowledge of meningioma epidemiology and new directions for research efforts in this field...
  50. ncbi request reprint Exogenous hormone use and meningioma risk: what do we tell our patients?
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut, USA
    Cancer 110:471-6. 2007
    ....

Research Grants22

  1. MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER
    Joellen Schildkraut; Fiscal Year: 2007
    ..Elucidation of the role of reproductive and environmental risk factors and genetic susceptibility could facilitate identification of high-risk women who would be ideal candidates for preventive interventions. ..
  2. The Molecular Epidemiology Of Ovarian Cancer
    Joellen M Schildkraut; Fiscal Year: 2010
    ..Ness), Los Angeles (Drs. Pearce and Wu) and Seattle (Dr. Rossing). Further confirmation will be pursued in collaboration with the Ovarian Cancer Association Consortium (OCAC) in the future. ..
  3. Meningioma: Risk Factors and Quality of Life
    Joellen Schildkraut; Fiscal Year: 2007
    ..This study represents the first concentrated effort to examine environmental and genetic risk factors for meningioma. ..
  4. The Molecular Epidemiology Of Ovarian Cancer
    Joellen Schildkraut; Fiscal Year: 2006
    ..Elucidation of the role of reproductive and environmental risk factors and genetic susceptibility could facilitate identification of high-risk women who would be ideal candidates for preventive interventions. ..
  5. MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER
    Joellen Schildkraut; Fiscal Year: 2001
    ..Published preliminary studies have already shown an association with abnormal expression of p53 in ovarian tumors and epidemiologic markers of ovulation. ..
  6. MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER
    Joellen Schildkraut; Fiscal Year: 2001
    ..Published preliminary studies have already shown an association with abnormal expression of p53 in ovarian tumors and epidemiologic markers of ovulation. ..
  7. MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER
    Joellen Schildkraut; Fiscal Year: 2002
    ..Published preliminary studies have already shown an association with abnormal expression of p53 in ovarian tumors and epidemiologic markers of ovulation. ..
  8. Meningioma: Risk Factors and Quality of Life
    Joellen Schildkraut; Fiscal Year: 2009
    ..This study represents the first concentrated effort to examine environmental and genetic risk factors for meningioma. ..
  9. CAROLINA AND GEORGIA GENETICS NETWORK CENTER
    Joellen Schildkraut; Fiscal Year: 2004
    ..Within this application, we propose to take advantage of our expertise and resources to ascertain registrants by augmenting referral services and by piloting the selective use of our unique registries. ..
  10. The Molecular Epidemiology Of Ovarian Cancer
    Joellen Schildkraut; Fiscal Year: 2004
    ..Elucidation of the role of reproductive and environmental risk factors and genetic susceptibility could facilitate identification of high-risk women who would be ideal candidates for preventive interventions. ..
  11. The Molecular Epidemiology Of Ovarian Cancer
    Joellen Schildkraut; Fiscal Year: 2009
    ..Ness), Los Angeles (Drs. Pearce and Wu) and Seattle (Dr. Rossing). Further confirmation will be pursued in collaboration with the Ovarian Cancer Association Consortium (OCAC) in the future. ..
  12. Meningioma: Risk Factors and Quality of Life
    Joellen M Schildkraut; Fiscal Year: 2010
    ..This study represents the first concentrated effort to examine environmental and genetic risk factors for meningioma. ..
  13. Epidemiology of Ovarian Cancer in African-American Women
    Joellen M Schildkraut; Fiscal Year: 2010
    ..This study will provide new insight into both the etiology and prognosis of ovarian cancer in African-American women. ..
  14. Meningioma: Risk Factors and Quality of Life
    Joellen Schildkraut; Fiscal Year: 2006
    ..This study represents the first concentrated effort to examine environmental and genetic risk factors for meningioma. ..
  15. The Molecular Epidemiology Of Ovarian Cancer
    Joellen Schildkraut; Fiscal Year: 2005
    ..Elucidation of the role of reproductive and environmental risk factors and genetic susceptibility could facilitate identification of high-risk women who would be ideal candidates for preventive interventions. ..
  16. MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER
    Joellen Schildkraut; Fiscal Year: 2003
    ..Elucidation of the role of reproductive and environmental risk factors and genetic susceptibility could facilitate identification of high-risk women who would be ideal candidates for preventive interventions. ..
  17. CAROLINA AND GEORGIA GENETICS NETWORK CENTER
    Joellen Schildkraut; Fiscal Year: 2002
    ..Within this application, we propose to take advantage of our expertise and resources to ascertain registrants by augmenting referral services and by piloting the selective use of our unique registries. ..
  18. MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER
    Joellen Schildkraut; Fiscal Year: 2000
    ..Published preliminary studies have already shown an association with abnormal expression of p53 in ovarian tumors and epidemiologic markers of ovulation. ..
  19. MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER
    Joellen Schildkraut; Fiscal Year: 1999
    ..Published preliminary studies have already shown an association with abnormal expression of p53 in ovarian tumors and epidemiologic markers of ovulation. ..
  20. Meningioma: Risk Factors and Quality of Life
    Joellen Schildkraut; Fiscal Year: 2009
    ..This study represents the first concentrated effort to examine environmental and genetic risk factors for meningioma. ..